-
1
-
2
-
1
-
2
Clearpol's Opinion of this Guidance as of 10/26/2012
Clearpol Inc. does not make any guarantees regarding the accuracy of the opinions provided on our platform. Please use your own judgement.
Clearpol's Summary of this Guidance

The California Department of Health has issued an All Facilities Letter regarding the ongoing investigation of contamination at the New England Compounding Center's (NECC) facility. The sterility of any injectable drugs, ophthalmic drugs, and cardioplegic solutions produced by NECC is of significant concern. Healthcare providers are recommended to contact patients who received these products and instruct them to seek immediate medical attention if they experience any symptoms. This is a result of a multistate fungal and bacterial meningitis outbreak associated with recalled lots of compounded methylprednisolone acetate. The letter advises facilities to follow up with patients who meet specific criteria, including receiving injectable products from NECC on or after May 21, 2012. This is an ongoing investigation, and information is subject to change daily. Healthcare facilities should visit the CDC or FDA MedWatch websites for the most up-to-date information on this outbreak.
Clearpol Inc. does not make any guarantees regarding the accuracy of the opinions or summaries provided on our platform. Please use your own judgement.
You have 0 new tasks available
Below are AI generated tasks related to this document. Accept or deny a task.
Task | Deadline | Actions |
---|
No suggested tasks available at the moment!
AI generated tasks related to this document are shown here. Tasks may be coming soon or you may have accepted/denied all the available tasks for this document.
The document is ready to print
Click below to print the document in a new window. When finished, you can return to this tab to continue.
Print PDF
Copy Document Link
Please enter a Name.
Please enter a valid email address.
Please enter a first name.
Please enter a last name.
Please enter a valid email address.